Supernus Pharm (SUPN) Misses Q3 EPS by 11c
Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.78), $0.11 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
